<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37037833</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI.</ArticleTitle><Pagination><StartPage>5808</StartPage><MedlinePgn>5808</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5808</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-32275-3</ELocationID><Abstract><AbstractText>Cognitive impairment is one of the most prevalent symptoms of post Severe Acute Respiratory Syndrome COronaVirus 2 (SARS-CoV-2) state, which is known as Long COVID. Advanced neuroimaging techniques may contribute to a better understanding of the pathophysiological brain changes and the underlying mechanisms in post-COVID-19 subjects. We aimed at investigating regional cerebral perfusion alterations in post-COVID-19 subjects who reported a subjective cognitive impairment after a mild SARS-CoV-2 infection, using a non-invasive Arterial Spin Labeling (ASL) MRI technique and analysis. Using MRI-ASL image processing, we investigated the brain perfusion alterations in 24 patients (53.0&#x2009;&#xb1;&#x2009;14.5&#xa0;years, 15F/9M) with persistent cognitive complaints in the post COVID-19 period. Voxelwise and region-of-interest analyses were performed to identify statistically significant differences in cerebral blood flow (CBF) maps between post-COVID-19 patients, and age and sex matched healthy controls (54.8&#x2009;&#xb1;&#x2009;9.1&#xa0;years, 13F/9M). The results showed a significant hypoperfusion in a widespread cerebral network in the post-COVID-19 group, predominantly affecting the frontal cortex, as well as the parietal and temporal cortex, as identified by a non-parametric permutation testing (p&#x2009;&lt;&#x2009;0.05, FWE-corrected with TFCE). The hypoperfusion areas identified in the right hemisphere regions were more extensive. These findings support the hypothesis of a large network dysfunction in post-COVID subjects with cognitive complaints. The non-invasive nature of the ASL-MRI method may play an important role in the monitoring and prognosis of post-COVID-19 subjects.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aj&#x10d;evi&#x107;</LastName><ForeName>Milo&#x161;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iscra</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furlanis</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michelutti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miladinovi&#x107;</LastName><ForeName>Aleksandar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buoite Stella</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukmar</LastName><ForeName>Maja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radiology Unit, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cova</LastName><ForeName>Maria Assunta</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Radiology Unit, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Accardo</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Engineering and Architecture, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manganotti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Trieste University Hospital-ASUGI, University of Trieste, Trieste, Italy. pmanganotti@units.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013113">Spin Labels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013113" MajorTopicYN="N">Spin Labels</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>10</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37037833</ArticleId><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-32275-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-32275-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb. Mortal Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: A 10-month study. J. Neurol. 2022;2022:1&#x2013;13. doi: 10.1007/s00415-022-11047-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite-Stella A, et al. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: A prospective multidomain observational study. J. Neurol. 2022;269:587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelutti M, et al. Sex-dependent characteristics of Neuro-Long-COVID: Data from a dedicated neurology ambulatory service. J. Neurol Sci. 2022;441:120355. doi: 10.1016/j.jns.2022.120355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120355</ArticleId><ArticleId IdType="pmc">PMC9328838</ArticleId><ArticleId IdType="pubmed">35994869</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19) Clin. Infect. Dis. 2021;73:e1089&#x2013;e1098. doi: 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J. Nucl. Med. 2021;62:910&#x2013;915. doi: 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH, et al. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur. J. Neurol. 2021;28:3245&#x2013;3253. doi: 10.1111/ene.14775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14775</ArticleId><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, et al. Cognitive decline and brainstem hypometabolism in long COVID: A case series. Brain Behav. 2022;12:e2513. doi: 10.1002/brb3.2513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2513</ArticleId><ArticleId IdType="pmc">PMC9014998</ArticleId><ArticleId IdType="pubmed">35290729</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme C, et al. COVID-19-related encephalopathy: A case series with brain FDG-positron-emission tomography/computed tomography findings. Eur. J. Neurol. 2020;27:2651&#x2013;2657. doi: 10.1111/ene.14478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14478</ArticleId><ArticleId IdType="pmc">PMC7461074</ArticleId><ArticleId IdType="pubmed">32881133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A, et al. The cerebral network of COVID-19-related encephalopathy: A longitudinal voxel-based 18F-FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2543&#x2013;2557. doi: 10.1007/s00259-020-05178-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05178-y</ArticleId><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Workman CD, Ponto LLB. 18F-FDG-PET imaging for post-COVID-19 brain and skeletal muscle alterations. Viruses. 2021;13:2283. doi: 10.3390/v13112283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112283</ArticleId><ArticleId IdType="pmc">PMC8625263</ArticleId><ArticleId IdType="pubmed">34835088</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxton RB, Uluda&#x11f; K, Dubowitz DJ, Liu TT. Modeling the hemodynamic response to brain activation. Neuroimage. 2004;23(Suppl 1):S220&#x2013;233. doi: 10.1016/j.neuroimage.2004.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2004.07.013</ArticleId><ArticleId IdType="pubmed">15501093</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos P, et al. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer&#x2019;s disease measured by pulsed arterial spin labeling MRI. Eur. Arch. Psychiatry Clin. Neurosci. 2012;262:69&#x2013;77. doi: 10.1007/s00406-011-0226-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-011-0226-2</ArticleId><ArticleId IdType="pubmed">21786091</ArticleId></ArticleIdList></Reference><Reference><Citation>Melzer TR, et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson&#x2019;s disease. Brain. 2011;134:845&#x2013;855. doi: 10.1093/brain/awq377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq377</ArticleId><ArticleId IdType="pmc">PMC3105489</ArticleId><ArticleId IdType="pubmed">21310726</ArticleId></ArticleIdList></Reference><Reference><Citation>BoscoloGalazzo I, et al. Patient-specific detection of cerebral blood flow alterations as assessed by arterial spin labeling in drug-resistant epileptic patients. PLoS ONE. 2015;10:e0123975. doi: 10.1371/journal.pone.0123975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0123975</ArticleId><ArticleId IdType="pmc">PMC4422723</ArticleId><ArticleId IdType="pubmed">25946055</ArticleId></ArticleIdList></Reference><Reference><Citation>Storti SF, et al. Combining ESI, ASL and PET for quantitative assessment of drug-resistant focal epilepsy. Neuroimage. 2014;102(Pt 1):49&#x2013;59. doi: 10.1016/j.neuroimage.2013.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2013.06.028</ArticleId><ArticleId IdType="pubmed">23792219</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinoto A, et al. ASL MRI and 18F-FDG-PET in autoimmune limbic encephalitis: Clues from two paradigmatic cases. Neurol. Sci. 2021;42:3423&#x2013;3425. doi: 10.1007/s10072-021-05207-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05207-0</ArticleId><ArticleId IdType="pubmed">33763811</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsop DC, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn. Reson. Med. 2015;73:102&#x2013;116. doi: 10.1002/mrm.25197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25197</ArticleId><ArticleId IdType="pmc">PMC4190138</ArticleId><ArticleId IdType="pubmed">24715426</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Plas MCE, Teeuwisse WM, Schmid S, Chappell M, van Osch MJP. High temporal resolution arterial spin labeling MRI with whole-brain coverage by combining time-encoding with Look-Locker and simultaneous multi-slice imaging. Magn. Reson. Med. 2019;81:3734&#x2013;3744. doi: 10.1002/mrm.27692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27692</ArticleId><ArticleId IdType="pmc">PMC6593668</ArticleId><ArticleId IdType="pubmed">30828873</ArticleId></ArticleIdList></Reference><Reference><Citation>Marterstock DC, et al. Pulsed arterial spin labeling and segmented brain volumetry in the diagnostic evaluation of frontotemporal dementia, Alzheimer&#x2019;s disease and mild cognitive impairment. Tomography. 2022;8:229&#x2013;244. doi: 10.3390/tomography8010018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tomography8010018</ArticleId><ArticleId IdType="pmc">PMC8788517</ArticleId><ArticleId IdType="pubmed">35076603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WSH, et al. MRI Assessment of cerebral blood flow in nonhospitalized adults who self-isolated due to COVID-19. J. Magn. Reson. Imaging. 2022 doi: 10.1002/jmri.28555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.28555</ArticleId><ArticleId IdType="pmc">PMC9877942</ArticleId><ArticleId IdType="pubmed">36472248</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirrotta F, et al. Italian validation of montreal cognitive assessment. Eur. J. Psychol. Assess. 2015;31:131&#x2013;137. doi: 10.1027/1015-5759/a000217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/1015-5759/a000217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, et al. The Montreal Cognitive Assessment (MoCA): Updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy. Aging Clin. Exp. Res. 2022;34:375&#x2013;382. doi: 10.1007/s40520-021-01943-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01943-7</ArticleId><ArticleId IdType="pmc">PMC8847194</ArticleId><ArticleId IdType="pubmed">34313961</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, et al. Fatigue in Parkinson&#x2019;s disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach. Parkinson. Relat. Disord. 2019;65:105&#x2013;110. doi: 10.1016/j.parkreldis.2019.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2019.05.028</ArticleId><ArticleId IdType="pubmed">31147224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell MA, Groves AR, Whitcher B, Woolrich MW. Variational Bayesian inference for a nonlinear forward model. IEEE Trans. Signal Process. 2009;57:223&#x2013;236. doi: 10.1109/TSP.2008.2005752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TSP.2008.2005752</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves AR, Chappell MA, Woolrich MW. Combined spatial and non-spatial prior for inference on MRI time-series. Neuroimage. 2009;45:795&#x2013;809. doi: 10.1016/j.neuroimage.2008.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2008.12.027</ArticleId><ArticleId IdType="pubmed">19162204</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxton RB, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn. Reson. Med. 1998;40:383&#x2013;396. doi: 10.1002/mrm.1910400308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.1910400308</ArticleId><ArticleId IdType="pubmed">9727941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell MA, et al. Partial volume correction of multiple inversion time arterial spin labeling MRI data. Magn. Reson. Med. 2011;65:1173&#x2013;1183. doi: 10.1002/mrm.22641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.22641</ArticleId><ArticleId IdType="pubmed">21337417</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum. Brain Mapp. 2002;15:1&#x2013;25. doi: 10.1002/hbm.1058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.1058</ArticleId><ArticleId IdType="pmc">PMC6871862</ArticleId><ArticleId IdType="pubmed">11747097</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Nichols TE. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83&#x2013;98. doi: 10.1016/j.neuroimage.2008.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2008.03.061</ArticleId><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Voruz P, et al. Long COVID neuropsychological deficits after severe, moderate, or mild infection. Clin. Transl. Neurosci. 2022;6:9. doi: 10.3390/ctn6020009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ctn6020009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, et al. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022;4:fcab295. doi: 10.1093/braincomms/fcab295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab295</ArticleId><ArticleId IdType="pmc">PMC8807287</ArticleId><ArticleId IdType="pubmed">35128398</ArticleId></ArticleIdList></Reference><Reference><Citation>Henri-Bhargava A, Stuss DT, Freedman M. Clinical assessment of prefrontal lobe functions. CONTINUUM Lifelong Learn. Neurol. 2018;24:704. doi: 10.1212/CON.0000000000000609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000609</ArticleId><ArticleId IdType="pubmed">29851874</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DT, Graff-Radford J. Executive dysfunction and the prefrontal cortex. Continuum (Minneap. Minn.) 2021;27:1586&#x2013;1601.</Citation><ArticleIdList><ArticleId IdType="pubmed">34881727</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S, et al. Dementia and COVID-19, a bidirectional liaison: Risk factors, biomarkers, and optimal health care. J. Alzheimers Dis. 2021;82:883&#x2013;898. doi: 10.3233/JAD-210335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210335</ArticleId><ArticleId IdType="pubmed">34092646</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, et al. The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P, et al. Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients. J. Neurol. 2021;268:3569&#x2013;3573. doi: 10.1007/s00415-021-10468-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10468-y</ArticleId><ArticleId IdType="pmc">PMC7951121</ArticleId><ArticleId IdType="pubmed">33709220</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>